Useful resources |
Terazosin for benign prostatic hyperplasia (Cochrane Review) ABSTRACT Background: Lower urinary tract symptoms associated with benign prostatic obstruction (BPO) occur in up to 70% of men over the age of 60 years. To relieve these bothersome symptoms, treatment options include alpha-antagonists, also know as alpha-blockers. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |